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Abstract 
Oxidative stress plays an important role in diabetes (DM)-associated vascular injury. 
DM is an important risk factor for erectile dysfunction (ED). Functional and structural 
changes in internal pudendal arteries (IPA) can lead to ED. We hypothesized that 
downregulation of Nrf2, consequent to increased NOX1-derived reactive oxygen 
species (ROS), impairs IPA function in diabetes. IPA and vascular smooth muscle 
cells (VSMC) from C57BL/6 (control) and NOX1 knockout (KO) mice were used. 
DM was induced by streptozotocin in C57BL/6 mice. Functional properties of IPA 
were assessed using a myograph, protein expression and peroxiredoxin oxidation by 
western blot, RNA expression by PCR, carbonylation by oxyblot assay, ROS 
generation by lucigenin, nitrotyrosine and amplex red, and Rho kinase activity and 
nuclear accumulation of Nrf2 by ELISA. IPA from diabetic mice displayed increased 
contractions to phenylephrine (control 138.5±9.5 vs. DM 191.8±15.5). ROS 
scavenger, Nrf2 activator, NOX1 and Rho Kinase inhibitors normalized vascular 
function. High Glucose (HG) increased ROS generation in IPA VSMC. This effect 
was abrogated by Nrf2 activation and not observed in NOX1 KO VSMC. HG also 
increased levels of nitrotyrosine, protein oxidation/carbonylation and Rho kinase 
activity, but reduced Nrf2 activity and expression of Nrf2-regulated genes [catalase 
(25.6%±0.05), HO-1 (21%±0.1) and NQO-1 (22%±0.1)] and hydrogen peroxide 
(H2O2) levels. These effects were not observed in VSMC from NOX1 KO. In these 
cells, HG increased H2O2 levels. In conclusion, Rho kinase activation, via NOX-1 
derived ROS and downregulation of Nrf2 system, impairs IPA function in diabetes. 
These data suggest that Nrf2 is vasoprotective in diabetes-associated ED. 
Key words: NOX1, Nrf2, Rho kinase, diabetes, internal pudendal artery, erectile 
dysfunction.  
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Introduction 
Erectile dysfunction (ED) is characterized by the inability to develop or maintain 
penile erection during sexual activity 
1
. In healthy subjects, penile erection depends 
on highly coordinated responses, involving relaxation of the pre- and intra-penile 
vasculature, leading to increased penile blood flow, increased intracavernosal pressure 
and penile tumescence 
2, 3
.  Arterial blood flow to the corpus cavernosum originates 
from the internal iliac arteries, courses to the internal pudendal arteries (IPA) and 
terminates in the bilateral cavernous arteries. Functional and structural changes in the 
IPA lead to ED 
4
. 
Diabetes Mellitus (DM) is an important risk factor for ED. Over 50% of men 
suffering from diabetes develop ED 
5-7
. In humans, DM is associated with stenosis 
and occlusion of IPA, which can compromise blood inflow to the corpora cavernosa 
and, consequently, impair erectile function 
8, 9
. Abnormalities in IPA are found in 
36.7% of diabetic patients 
10
. Although it may be expected that IPA display DM-
associated dysfunction 
11
, almost no studies have addressed the function of IPA in 
DM 
12
.  
Hyperglycemia, hyperlipidemia and inflammation, three main metabolic 
abnormalities in DM, induce reactive oxygen species (ROS) generation and oxidative 
stress. Oxidative stress, defined as a disturbance in the production of ROS or in the 
ability of the antioxidant defenses to neutralize ROS, is critically involved in DM-
associated complications, including nephropathy, cardiomyopathy, endothelial 
dysfunction and ED 
6, 13-15
.  
Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) is 
the main source of ROS in the vasculature. Seven NADPH oxidase isoforms have 
been identified (NOX1–5, Duox1, Duox2) 16, with NOX1 playing an important role in 
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vascular smooth muscle cells (VSMC) proliferation, migration, and extracellular 
matrix production 
17
. Increased NOX1 expression is consistently reported in vascular 
cells from animal models of cardiovascular and metabolic diseases, such as arterial 
hypertension, atherosclerosis, hypercholesterolemia and DM 
18, 19
.  However, it is not 
clear whether abnormal NOX1 activity plays a role in diabetes-associated ED. 
Nuclear factor E2-related factor 2 (Nrf2) is the main mediator of cellular 
adaptation to redox stress i.e. is the main negative regulator of oxidative stress. Nrf2 
signaling activates the transcription of many key antioxidant genes, such as heme 
oxygenase-1 (HO-1), NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione S-
transferase (GST) and glutathione peroxidase. Under basal conditions, the protein 
Keap1 interacts with Nrf2 in the cytoplasm, keeping Nrf2 inactivated. Cellular 
stressors, such as ROS lead to oxidation of cysteine residues in Keap1, inducing Nrf2 
release and translocation into the nucleus. Nrf2 binds to antioxidant response element 
in the upstream promoter region of many antioxidant genes, promoting their 
transcription 
20-22
.  
Therefore, considering that NADPH oxidase and Nrf2 signaling have been 
identified as the main vascular source and negative regulator of ROS, respectively; 
that NOX1 is involved in diabetes-associated vascular complications; and that 
alterations in function and structure of IPA lead to ED, we hypothesized that 
downregulation of Nrf2-regulated enzymes, consequent to increased NOX1-derived 
ROS, impairs IPA function in diabetic mice. 
 
Materials and Methods 
Expanded Materials and Method section is available in the Supplemental Text on-line 
Animals and experimental model of diabetes 
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The study is in accordance with the Ethical Principles in Animal Research adopted by 
the National Council for the Control of Animal Experimentation (CONCEA), and was 
approved by the Local Animal Ethical Committee from the School of Medicine of 
Ribeirao Preto of the University of Sao Paulo (protocol 068/2013). In addition the 
studies were conducted in accordance with the Animals Scientific Procedures Act 
1986. Male, C57BL/6 and NOX1 knockout (KO) mice were housed in individually 
cages in a room with controlled humidity and temperature, and light/dark cycles of 12 
h.  Animals had free access to food and potable tap water. To induce type-1 diabetes, 
ten weeks-old C57BL/6 mice received intraperitoneal injections of streptozotocin 
(STZ - Sigma Aldrich, 50 mg/kg/day, for 5 days).  Blood glucose concentration was 
measured weekly (for 4 weeks) from the day of STZ first injection. Blood samples 
were obtained weekly by nicking the lateral tail vein using a sterile scalpel blade. 
Functional studies in internal pudendal arteries 
Internal pudendal arteries were cut into 2 mm ring segments and mounted on a wire 
myograph, as previously described 
23
. After 60 minutes of stabilization, the contractile 
ability of the preparations was assessed by adding KCl solution to the organ baths. 
Endothelium integrity was verified by relaxation induced by acetylcholine (Ach 10
-6
 
M – Sigma Aldrich) in IPA contracted with phenylephrine (Phe 10-6 M- Sigma 
Aldrich). To determine endothelium-dependent vasodilatation, ACh was used in 
vessels pre-contracted with the thromboxane A2 analogue U46619 10
-6
 M (Tocris). 
Isolation of vascular smooth muscle cells from internal pudendal arteries 
VSMC were dissociated by digestion of arteries with enzymatic solution and cultured 
as we described 
24
. Before experimentation, cell cultures were rendered quiescent by 
serum deprivation (0.5% FBS). Low-passage cells (passages 4–7) were used in our 
experiments. 
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Lucigenin-enhanced chemiluminescence. 
VSMC from IPA were stimulated with HG medium (25 mM) at different time points 
– from 15 min to 24 h. In some experiments, cells will were pre-exposed to ML171. 
After stimulation, cells were washed and harvested in lysis buffer. NADPH (10
−4
 M) 
was added to the suspension containing lucigenin (5 µM). Luminescence was 
measured before and after stimulation with NADPH. A buffer blank was subtracted 
from each reading. The results are expressed as percentage of control, in arbitrary 
units per microgram of protein, as measured by the Bradford assay. 
Amplex red 
Measurement of vascular hydrogen peroxide (H2O2) levels was performed using the 
fluorescence assay Amplex
®
 Red Hydrogen Peroxide/Peroxidase Assay Kit 
(Molecular Probes
®
), according to the manufacturer's instructions. Cellular protein 
levels, measured by Bradford assay, were used to normalize H2O2 production. The 
results are expressed in arbitrary units per milligram protein. 
Nrf2 and Rho kinase activity 
To determine nuclear accumulation of Nrf2, nuclear cell lysates were separated using 
the Active Motif nuclear extract kit (Active Motif, Carlsbad, CA) following the 
manufacturer's protocol. Rho kinase activity was measured with a Rho Kinase 
Activity Assay Kit (Cell Biolabs). 
Immunoblotting 
Quiescent VSMC were stimulated with HG and proteins extracted, separated by 
electrophoresis on a polyacrylamide gel and transferred to a nitrocellulose membrane. 
Nonspecific binding sites were blocked with 5% bovine serum albumin in Tris-
buffered saline solution. Membranes were then incubated with specific antibodies, 
overnight at 4°C. Membranes were washed three times with TBS-Tween 20 and 
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incubated with specific secondary antibodies for 1 h at room temperature. Signals 
were revealed after reaction with enhanced chemiluminescence. Results were 
normalized by the total protein content and are expressed relatively to control (100%) 
in the experimental protocols.  
Protein oxidation  
Levels of protein-tyrosine phosphatases (PTPs) and peroxiredoxin oxidation were 
evaluated by western blot and carbonylation by oxyblot assay (Millipore). VSMC 
isolated from C57BL/6 and NOX1 KO mice were stimulated with HG medium and 
levels of protein oxidation were measured. 
Real-time PCR 
Briefly, total RNA extracted from VSMC (Trizol
®
) was treated with RNase-free 
DNase I, and 2 μg of RNA were reverse-transcribed in a reaction containing oligo dT. 
For real-time PCR amplification, 2 μL of each reverse transcription product were 
diluted in a reaction buffer containing: 5 μL SYBR® Green PCR master mix and 
900 nmol/L primers in a final volume of 10 μL per sample. Data were analyzed by the 
2
Ct
 method and the results expressed relatively to control. 
Statistical analysis 
Data are presented as mean ± standard error of the mean (SEM). Statistical 
comparisons were made with one-way ANOVA followed by Tukey's post-test or two-
tailed Student’s t-test when appropriate. p<0.05 was considered statistically 
significant. 
 
Results 
IPA dysfunction in diabetic mice is reversed by Tiron and ML171. 
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Streptozotocin increased blood glucose levels (supplemental figure S1A) within the 
first week of treatment, which was followed by a decrease in body weight 
(supplemental figure S1B). 
IPA isolated from diabetic mice exhibited increased Phe-induced constriction 
(figure 1), which was abrogated by Tiron, a ROS scavenger (figure 1B) and by 
ML171, a NOX1 inhibitor (figure 1C). Decreased ACh-induced dilation was also 
observed in IPA from diabetic mice (supplemental figure S2A), which was reversed 
by Tiron (supplemental figure S2B) and ML171 (supplemental figure S2C).  
NOX1 contributes to High Glucose-induced ROS generation in IPA VSMC. 
In diabetes, vascular cells are constantly exposed to high concentrations of glucose. 
To determine molecular mechanisms involved in NOX1-associated IPA dysfunction 
in diabetic animals, VSMC isolated from IPA of C57BL/6 and NOX1 KO mice were 
exposed to HG medium (25 mM D-glucose). Preliminary experiments with IPA 
VSMC exposed to HG at different time points – from 15 min to 24 h - demonstrated 
ROS generation after 2, 4 and 16 h. Therefore, for further experiments ROS 
generation was determined after exposure of IPA VSMC to HG medium (25 mM) for 
2 and 16 h (Supplemental figure S3A).  As observed in figure 2, HG stimulated ROS 
generation (A), increased nitrotyrosine levels (B) and decreased H2O2 levels (C), 
effects not observed in cells isolated from NOX1 KO mice (figures 2D-2F). ROS 
generation was not observed in C57BL/6 VSMC maintained in medium containing 
the L-glucose isomer (25 mM), used as an osmotic control (Supplemental figure 
S1C). NOX1 protein expression was determined in VSMC to confirm NOX1 KO 
genotype (Supplemental figure S1D). ROS generation induced by HG medium was 
also observed in endothelial cells. Preliminary experiments in endothelial cells 
exposed to HG at different time points – from 5 min to 16 h - demonstrated ROS 
  
9 
9 
generation at various time points, except at 16 h (supplemental figure S3B). 
Therefore, for further experiments ROS generation was determined after exposure of 
endothelial cells to HG medium (25 mM) for 30 min and 4 h. 
NOX1 contributes to High Glucose-induced protein oxidation in IPA VSMC. 
ROS generation modulates many vascular processes via oxidation of proteins, such as 
protein-tyrosine phosphatases (PTPs). ROS also influence phosphorylation of PTPs, 
thereby modulating PTPs activity. PTPs oxidation, which renders the enzymes 
inactive, was increased in IPA VSMC maintained in HG for 2 h (figure 3A), an effect 
not observed in NOX1 KO cells. Peroxiredoxin (PRDX) oxidation (figure 3B-C), as 
well as carbonylation (figure 3D-E), another type of irreversible oxidation induced by 
oxidative stress, was also increased in HG-treated VSMC from C57BL/6, but not in 
NOX1 KO cells.  
High Glucose downregulates Nrf2 signaling in IPA VSMC. 
Considering that Nrf2 signaling is a major regulator of endogenous antioxidant 
systems, we evaluated whether HG interferes with Nrf2 signaling in IPA VSMC. HG 
decreased nuclear accumulation of Nrf2 (figure 4A), as well as total levels of Nrf2 
(supplemental figure S3C) in IPA VSMC from C57BL/6, which was followed by a 
decrease in mRNA expression of Nrf2-regulated enzymes (figure 4B), such as 
catalase, HO-1, NQO1 and PRDX, events not observed in IPA VSMC isolated from 
NOX1 KO mice (figures 4C and 4D), indicating that the process is regulated by 
NOX1. NOX1 inhibition by ML171 also reversed the decrease in Nrf2-regulated 
enzymes induced by HG in IPA VSMC from C57BL/6 mice (supplemental figure 
S4). In addition, activation of the Nrf2 system by L-sulforaphane and bardoxolone 
decreased HG-induced ROS generation in IPA VSMC from C57BL/6 (figure 4E) and 
abrogated IPA dysfunction in diabetic mice (figure 4F), respectively.  
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ROS generation by endothelial cells, as well as decreased nuclear accumulation of 
Nrf2 induced by HG was abrogated by NOX1 inhibition and Nrf2 activation 
(supplemental figures S5A and S5B). Activation of Nrf2 by Bardoxolone also 
reversed reduced endothelium-dependent vasodilatation in diabetic mice 
(supplemental figure S5C). 
NOX1 contributes to High Glucose-induced Rho kinase activation in IPA 
VSMC. 
To determine molecular mechanisms by which NOX 1-derived ROS induce IPA 
dysfunction, vascular reactivity was evaluated in the presence of Y27632, an inhibitor 
of the redox-sensitive protein Rho kinase, which modulates vasoconstriction. The Rho 
kinase inhibitor abrogated increased vasoconstriction to Phe in diabetic mice (Figure 
5A). To determine the involvement of NOX1 in Rho kinase activation, VSMC 
isolated from C57BL/6 and NOX1 KO mice were maintained in HG. In basal 
conditions, Rho kinase activity was downregulated in cells isolated from NOX1 KO 
mice, and HG increased Rho kinase activity only in cells from C57BL/6 mice (figure 
5B), but not in VSMC from NOX1 KO mice. Similar results were found in the 
analysis of phosphorylation levels of the Rho kinase target, myosin phosphatase target 
subunit 1 (MYPT1) (figure 5 C), a regulatory subunit of protein phosphatase 1. 
 
Discussion 
Major findings from the present study demonstrate that in diabetes, a condition 
associated with vascular oxidative stress, (1) internal pudendal artery function is 
abnormal; (2) Nrf2 signaling and Nrf2-regulated antioxidant enzymes are 
downregulated through mechanisms involving NOX1-derived ROS; (3) activation of 
Nrf2 signaling or inhibition of NOX1 restores IPA function; (4) NOX1-derived ROS 
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leads to protein oxidation and IPA dysfunction via activation of the Rho Kinase 
pathway. These findings indicate that dysregulation in NOX1-derived ROS and Nrf2-
antioxidant system contributes to oxidative stress and are associated with IPA 
dysfunction in diabetes. Decreased Nrf2 activation and increased NOX1-derived ROS 
impact IPA function in diabetic mice, which are normalized by Nrf2 activators and 
NOX1 inhibition. The vasoprotective actions of these drugs may be clinically 
important in diabetes-associated erectile dysfunction, where IPA function and 
structure are compromised. 
 Experimental and clinical evidence suggests an important role for ROS in 
diabetes-associated complications. Glucose-stimulated ROS generation in human 
aortic endothelial cells is attenuated by siRNA targeted against NOX1 and by 
treatment with GKT137831, a NOX inhibitor. In addition, development of 
atherosclerosis in diabetic animals is reduced by deletion of NOX1 or treatment of 
ApoE
−/−
 mice with GKT137831 
25
. Treatment of obese and diabetic db/db mice with 
NOX inhibitors also reduces albuminuria, oxidative stress (TBARS levels), renal 
ERK1/2 phosphorylation and fibrosis 
26
. Additional studies have shown the potential 
use of ROS scavengers in salvaging erectile function in diabetic condition 
27, 28
. In 
corpora cavernosa from streptozotocin-induced diabetic rats, antioxidant treatment 
improves SOD activity, increases endothelial NO synthase expression and reduces 
ROS generation in corpora cavernosa, followed by an improvement in Intracavernosal 
Pressure/Mean Arterial Pressure ratio 
29
.  
Despite the evidence that diabetes is an important risk factor for erectile 
dysfunction, very little is known about internal pudendal artery function in diabetic 
conditions, and even less is known about the involvement of any catalytic core 
subunit of NOX, such as NOX1, in IPA function in diabetes. Our results reinforce an 
  
12 
12 
important role of ROS in diabetes-associated IPA dysfunction, since the absence of 
NOX1 or NOX1 inhibition reduced ROS generation, prevented activation of Rho 
kinase signaling, and restored vascular function. Of importance, NOX1 inhibition 
reversed diabetes-induced downregulation of the major antioxidant regulator, Nrf2. 
Decreased Nrf2 expression may account for the reduced Nrf2 nuclear accumulation. 
NOX1 inhibition may facilitate nuclear accumulation of Nrf2 in hyperglycemic states 
by decreasing Nrf2 degradation. Many mechanisms have been suggested as regulators 
of Nrf2 levels, such as the classic canonical mechanism (Keap1) 
30
,  the redox-
insensitive degron within the Neh6 domain of Nrf2 
31
 and suppression of Nrf2 via 
Hrd1 E3 ubiquitin ligase 
32
. Other proteins, such as dipeptidyl peptidase 3 (DPP3), 
and the positive regulator of Nrf2, p62 protein, compete with Nrf2 for Keap1 binding, 
thus stabilizing Nrf2 
33
. In addition, NOX1 knockdown prevented high glucose-
induced decreased H2O2 levels in IPA VSMC. Considering the beneficial effects of 
H2O2 
34-36
, the decrease in H2O2 levels after high glucose exposure points out to 
additional mechanisms by which diabetes induces vascular damage. We have not 
determined which signal is responsible for NOX1 activation in IPA VSMC stimulated 
with HG, or whether NOX1 is the primary point or is activated by a preceding signal 
induced e.g. by advanced glycation end products or a metabolic product of HG 
conversion. Additional studies are needed to clarify these questions. 
 Supporting our results, other studies have shown that Nrf2 is dysregulated in 
experimental models of diabetes whereas Nrf2 activation has protective effects. 
Zheng et al. 
37
 demonstrated that Nrf2 activators reduce renal injury and improve the 
metabolic profile in a model of streptozotocin-induced diabetes, In diabetic kidneys, 
treatment with L-sulforaphane reduced oxidative stress, expression of the profibrotic 
mediator transforming growth factor-β, and extracellular matrix proteins, effects not 
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observed in Nrf2-deficient diabetic animals, which reinforces L-sulforaphane 
specificity 
37
.  In mesenteric arteries from db/db mice, decreased Nrf2 activity 
contributes to increased ROS generation and increased vasoconstriction.  Treatment 
with L-sulforaphane lowered ROS levels in db/db mice and reduced myogenic tone to 
levels comparable to those in vessels from control animals 
38
. However, some studies 
demonstrated deleterious effects of Nrf2. The Nrf2 activator bardoxolone worsened 
proteinuria, glomerulosclerosis and tubular damage in a model of type 2 diabetes 
39, 40
 
as well as renal function in a phase II clinical trial 
41
. In addition, a trial was 
prematurely terminated due to higher incidence of heart failure and mortality in 
bardoxolone-treated patients 
42
. Additional studies demonstrated that whereas low 
doses of Nrf2 activators are protective, high doses lead to deleterious outcomes 
40, 43
. 
 In basal conditions, Keap1, which regulates Nrf2 ubiquitination via Cul3-
Keap1, keeps Nrf2 in the cytosol. In oxidative stress conditions, it is expected that 
Cul3-Keap1-E3 ligase is inhibited by oxidation, releasing Nrf2, which translocates to 
the nucleus, binds to antioxidant response element and initiates transcription of 
antioxidant enzymes 
44, 45
. However, in diabetic conditions Nrf2 signaling is impaired, 
as observed by decreased nuclear accumulation of Nrf2 in IPA VSMC exposed to 
high glucose medium. As a result, high glucose induces NOX1-derived ROS 
generation, but Nrf2 translocation and expression of antioxidant enzymes regulated by 
this pathway are decreased. Interestingly, NOX1 regulates these processes, since in 
VSMC from NOX1 deficient mice, nuclear accumulation of Nrf2 was preserved upon 
exposure to high glucose. 
ROS are intracellular signaling molecules that modulate several cellular 
responses, such as inhibition of PTPs via oxidation of conserved cysteine residues 
46
. 
The nucleophilic property of PTPs needed for substrate dephosphorylation is inhibited 
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by oxidation, which renders these enzymes inactive 
47
. In this study, we explored the 
potential of irreversible oxidation as a mechanism for regulation of PTP function. 
Stimulation of IPA VSMC cells with high glucose increased ROS generation and 
concomitantly inhibited PTPs, effects not observed in cells isolated from NOX1 KO 
animals, confirming that PTPs abnormalities are due to NOX1-induced intracellular 
oxidation. The inactivation of PTPs in IPA VSMC likely promotes augmented 
phosphorylation of various signaling proteins, which can contribute to diabetes-
associated IPA dysfunction. A few studies corroborate our results. VSMC isolated 
from mesenteric artery from WKY and SHRSP rats 
48
 and retinal from rats and mice 
49
 exposed to hyperglycemia present increased expression of the PTP, PTP1B,  
Protein carbonylation is a post-translational modification where carbonyl 
groups are introduced into proteins. It is considered a biomarker for oxidative stress-
induced irreversible damage and leads to loss of protein function 
50
. High Glucose 
induced protein carbonylation in IPA VSMC from C57BL/6 mice is regulated by 
NOX1, since this was not observed in cells from NOX1 knockout animals. Of 
importance, peroxiredoxin was also targeted by High Glucose-induced oxidation via 
NOX1. Hyperoxidation of peroxiredoxin leads to its inactivation 
51
, which makes IPA 
VSMC vulnerable to damage associated with oxidative stress. More studies are 
needed to determine the involvement of carbonylation, and oxidation of peroxiredoxin 
and PTPs and, consequently, augmented phosphorylation of proteins in IPA 
dysfunction. These proteins may represent targets in erectile dysfunction associated 
with impaired IPA function.  
Several signaling proteins that modulate vascular reactivity, including the 
regulatory myosin binding subunit (MYPT1) in myosin light chain phosphatase, are 
regulated by oxidative stress. The classical Rho kinase signaling involves 
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phosphorylation of MYPT1, which decreases the ability of myosin light chain 
phosphatase to dephosphorylate myosin light chain, thereby maintaining vascular 
contractility 
52
. However, additional Rho kinase actions have been proposed. 
Inhibition of Rho kinase by fasudil reverses hypercholesterolemia-induced 
downregulation of Nrf2-regulated enzymes such as catalase, glutathione peroxidase 
and SOD in rats 
53
. Fasudil also reverses stroke-associated increased superoxide anion 
levels in endothelial cells 
54
, suggesting a cross-talk between Rho kinase and redox 
signaling. Regarding a role for Nrf2/Rho kinase in the erectile function process, it has 
been reported that increased Rho kinase activity contributes to impaired corpora 
cavernosa relaxation in streptozotocin-induced diabetes 
55
 and also in db/db mice, an 
experimental model that exhibit downregulation of Nrf2-regulated antioxidant 
enzymes 
56
. Rho kinase inhibition also reduces ET-1-mediated IPA constriction in 
type 2 diabetic female rats 
12
 and increases intracavernosal pressure and rat penile 
erection induced by cavernous nerve stimulation 
57
. Our data showing that Rho kinase 
activation in IPA from diabetic mice is an event regulated by NOX1-derived ROS 
further highlight the relevance of IPA-Nrf2/Rho kinase in the erectile function process 
and indicate that NOX1 inhibitors and Nrf2 activators may be important candidates to 
treat erectile dysfunction associated with Rho kinase-induced IPA dysfunction.  
 In conclusion, NOX1-derived ROS leads to internal pudendal artery 
dysfunction via Nrf2 downregulation and Rho kinase activation in diabetic mice.  
These findings suggest that NOX1 activation, or blunting of Nrf-2 signaling, 
contributes to reduced antioxidant potential, increased oxidative stress and protein 
oxidation and IPA dysfunction in diabetic animals. Normalization of these alterations 
by Nrf2 agonists may have therapeutic potential in IPA dysfunction and erectile 
dysfunction in diabetes. 
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Representative diagram with findings of the present study. Diabetes increases 
NOX1-derived ROS generation and decreases Nrf2 signaling, which lead to protein 
oxidation and Rho kinase activation culminating in internal pudendal artery 
dysfunction. IPA: Internal Pudendal Artery. 
Perspectives 
Diabetes is associated with cellular and vascular dysfunction induced by failure of 
defences against oxidative stress. Increased NOX1 expression is consistently reported 
in vascular dysfunction in models of cardiovascular and metabolic diseases. Nrf2 via 
regulation of the expression of antioxidant enzymes is involved in protection against 
oxidative stress. Our results identify vasoprotective effects of Nrf2 agonists in internal 
pudendal artery, which may have therapeutic potential in diabetes-associated erectile 
dysfunction. 
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NOVELTY AND SIGNIFICANCE 
What Is New? 
This study demonstrates that NOX1 activation and blunting of Nrf-2 signaling, 
contributes to reduced antioxidant potential, increased oxidative stress and protein 
oxidation, leading to internal pudendal artery dysfunction via Rho kinase activation in 
diabetic animals. 
What Is Relevant? 
In Diabetes: 
1. Internal pudendal artery function is abnormal 
2. Nrf2 signaling and Nrf2-regulated antioxidant enzymes are downregulated in IPA 
through mechanisms involving NOX1-derived ROS 
3. Activation of Nrf2 signaling or inhibition of NOX1 restores IPA function 
4. NOX1-derived ROS leads to protein oxidation and IPA dysfunction via activation 
of the Rho Kinase pathway 
Summary 
NOX1-derived ROS leads to internal pudendal artery dysfunction via Nrf2 
downregulation and Rho kinase activation in diabetic mice.   
 
Figure legends 
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Figure 1. IPA dysfunction in diabetic mice is abrogated by Tiron and ML171. 
Concentration-response curves to Phe were performed in IPA isolated from control 
and diabetic mice, in the presence of vehicle, tiron or ML171. IPA were exposed to 
Tiron (10
-4
 M), ML171 (10
-6
 M) and vehicle solutions for 30 min before Phe 
concentration-response curves. Contractions were normalized by responses to KCl 
120 mM. The points represent the mean ± SEM (n = 7). * p<0.05 vs. Control. 
 
Figure 2. High Glucose-induced ROS generation is not observed in NOX1 KO 
VSMC. The experiments were performed in VSMC isolated from IPA of C57BL/6 
(A-C) and NOX1 KO (D-F) mice, in basal conditions (control) or after exposure to 
HG (for 2 and 16 h). ROS generation was measured by lucigenin (A, D), peroxinitrite 
by nitrotyrosin assay (B, E) and H2O2 levels by amplex red (C, F). The values were 
normalized by the amount of protein. Bars represent the mean ± SEM (n = 6-8). * 
p<0.05 vs. control.  
 
Figure 3. NOX1 contributes to High Glucose-induced protein oxidation in IPA 
VSMC. The experiments were performed in VSMC isolated from IPA of C57BL/6 
and NOX1 KO mice, in basal conditions (control) or in cells stimulated with HG (for 
2 and 16 h). oxPTP (A) and PRDX-SO3 (B-C) oxidation was assessed by western 
blot; protein carbonylation (D-E) was assessed by oxyblot. The values were 
normalized by α-tubulin (A-C) or β-actin (D, E). Bars represent the mean ± SEM (n = 
6). * p<0.05 vs. control. 
 
Figure 4. High Glucose-induced IPA dysfunction involves Nrf2 downregulation. 
The experiments were performed in VSMC isolated from IPA from C57BL/6 and 
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NOX1 KO mice in basal conditions (control) or in cells stimulated with HG (for 2, 4 
and 16 h). Nuclear accumulation of Nrf2 was determined by ELISA in nuclear extract 
of VSMC isolated from C57BL/6 and NOX1 KO mice (A, C). mRNA expression of 
genes regulated by Nrf2 was determined by RT-PCR (B). ROS generation was 
evaluated by lucigenin assay (D), and vascular reactivity by wire myograph (E). The 
values were normalized by protein measurement (A, C, D), by GAPDH mRNA 
expression (B) or by responses to KCl 120 mM (E). When used, L-sulforaphane 
(5x10
-6
 M) or Bardoxolone (10
-6
 M) was added 3 h prior to the experiment. Bars 
represent the mean ± SEM (n = 6). * p<0.05 vs. control. Points in the concentration-
response curves represent the mean ± SEM (n = 7). * p<0.05 vs. control.  
 
Figure 5. NOX1-derived ROS contributes to High Glucose-induced Rho kinase 
activation in IPA VSMC. The experiments were performed in isolated IPA (A) or 
VSMC isolated from IPA (B, C) from C57BL/6 and NOX1 KO mice. VSMC were 
stimulated with High Glucose at different time points (2, 8 and 16 h). Vascular 
reactivity (A) was assessed by wire myograph, Rho kinase (B) by ELISA and MYPT 
1 phosphorylation (C) by western blot.  When used, Y27632 (10
-6
 M) was added 30 
min prior to the experiment. The values were normalized by responses to KCl 120 
mM (A) or protein measurement (B-C). Alpha-tubulin was used as an internal control 
in the western blotting experiments. Bars represent the mean ± SEM (n = 6). * p<0.05 
vs. control. Points in the concentration-response curves represent the mean ± SEM (n 
= 7). * p<0.05 vs. control.  
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Expanded Materials and Method 
Isolation of vascular smooth muscle cells from internal pudendal arteries 
Internal pudendal arteries isolated from non-diabetic animals (C57BL/6 and NOX1 
KO) were cleaned of adipose and connective tissue. VSMC were dissociated by 
enzymatic digestion and cell suspensions were centrifuged and resuspended in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with bovine fetal serum 
(10%). Low-passage cells (passages 4–7) from different primary cultures were used in 
our experiments. To mimic diabetic conditions, VSMC from IPA were stimulated 
with High Glucose (HG) medium (25 mM). The L-glucose isomer (25 mM) was used 
as an osmotic control (Supplemental figure S1C). VSMC were identified by 
determination of α-actin expression by fluorescence microscopy, and the absence of 
endothelial cells was confirmed by assessment of von Willebrand factor by real-time 
polymerase chain reaction (PCR; data not shown). Rat aortic endothelial cells were 
purchased from Public Health England/ECACC (catalog number: 06090770). 
 
Nrf2 and Rho kinase activity 
To determine nuclear accumulation of Nrf2, nuclear cell lysates were separated using 
the Active Motif nuclear extract kit (Active Motif, Carlsbad, CA) following the 
manufacturer's protocol. Briefly, cells were resuspended in 1X hypotonic buffer and 
centrifuged for 30 seconds at 14,000 g in a microcentrifuge pre-cooled at 4
o 
C. 
Nuclear pellets were resuspended in lysis buffer provided by the manufacturer. The 
suspension was incubated for 30 min on ice on a rocking platform set at 150 rpm and 
then centrifuged for 10 minutes at 14,000 g. The supernatant was transferred to a pre-
chilled microcentrifuge tube. TransAM Nrf2 ELISA kit (Active Motif) was used to 
measure nuclear accumulation of Nrf2 at a wavelength of 450 nm. 
Rho kinase activity was measured with a Rho Kinase Activity Assay Kit (Cell 
Biolabs). Briefly, samples were added to the plate and incubated for 60 minutes under 
gentle agitation. Each microwell was washed 3 times with 250 μL 1X Wash Buffer 
with thorough aspiration between each wash. Diluted anti-phospho-MYPT1 (Thr
696
) 
was added and incubated for 1 h on an orbital shaker. Subsequently, 100 μL of the 
diluted horseradish peroxidase-conjugated secondary antibody was added to each well 
and incubated for 1 h. After addition of the stop solution (provided by the company), 
absorbance of each microwell was read on a spectrophotometer using 450 nm as the 
primary wavelength. 
 
Functional studies in internal pudendal arteries 
Internal pudendal arteries were cut into 2 mm ring segments and mounted on a wire 
myograph, as previously described 
1
. The relationship between resting wall tension 
and internal circumference was determined, and the internal circumference, L100, 
corresponding to a transmural pressure of 100 mmHg for a relaxed vessel in situ, was 
calculated. The vessels were set to the internal circumference L1, given by L1 = 
0.9×L100. The effective internal lumen diameter was determined as L1 = L1/π, and 
was between 200 and 300 µm. After 60 minutes of stabilization, the contractile ability 
of the preparations was assessed by adding KCl solution to the organ baths. 
Endothelium integrity was verified by relaxation induced by acetylcholine (Ach 10
-6
 
M – Sigma Aldrich) in IPA contracted with phenylephrine (Phe 10-6 M- Sigma 
Aldrich). To determine endothelium-dependent vasodilatation, ACh was used in 
vessels pre-contracted with the thromboxane A2 analogue U46619 10
-6
 M (Tocris). 
When used, Tiron 10
-4
 M (ROS scavenger) and ML171 10
-6
 M (NOX1 inhibitor) 
were incubated 30 min prior to the concentration-response curves. To activate Nrf2 
system, L-sulforaphane and Bardoxolone were incubated for 3 h, as previously 
described 
2
. Both drugs reversibly interact with critical nucleophilic free thiol groups 
of cysteine residues on Keap1, which results in the translocation of Nrf-2 to the 
nucleus and subsequent activation of a range of antioxidant response element-
responsive genes 
2-4
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Figure	S1.	Streptozotocin	injec ons	in	C56BL/6	mice	increase	blood	glucose	levels	and	decrease	body	weight.	Blood	
glucose	concentra on	(A)	and	body	weight	(B)	were	measured	weekly	(for	4	weeks)	from	the	day	of	STZ	injec on.	
Blood	samples	were	obtained	by	nicking	the	lateral	tail	vein	using	a	sterile	scalpel	blade.	IPA	VSMC	were	s mulated	
with	L-glucose	(osmo c	control)	and	ROS	genera on	was	measured	by	lucigenin	(C).	Blot	to	NOX1	was	performed	to	
confirm	the	absence	of	NOX	1	protein	in	VSMC	isolated	from	NOX1	KO	mice	(D).	Bars	represent	the	mean	±	SEM	(n	=	
6).	*	p<0.05	vs.	Control.	
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Figure	S3.	High	Glucose	induces	ROS	genera on	in	VSMC	and	endothelial	cells.	The	
experiments	were	performed	in	homogenate	of	VSMC	isolated	from	IPA	of	C57BL/6	mice	
(A,C)	or	rat	aor c	endothelial	cells	(B).	ROS	genera on	was	measured	by	lucigenin	and	Nrf2	
levels	by	western	blot.	The	values	were	normalized	by	the	amount	of	protein	or	β-ac n.	Bars	
represent	the	mean	±	SEM	(n	=	7-8).	*	p<0.05	vs.	control.		
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